FDA approves Outlook Therapeutics’ LYTENAVA for the treatment of wet AMD
FDA approves Outlook Therapeutics' LYTENAVA for the treatment of wet AMD Ophthalmology Times Europe
FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis
FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis The American Journal of Managed Care
US FDA approves Outlook Therapeutics’ eye disease drug
US FDA approves Outlook Therapeutics' eye disease drug Reuters
FDA approves acetaminophen-naproxen sodium combination tablet for ages 12 and older
FDA approves acetaminophen-naproxen sodium combination tablet for ages 12 and older Contemporary Pediatrics
FDA Approves First OTC Acetaminophen–Naproxen Combination for 12-Hour Pain Relief
FDA Approves First OTC Acetaminophen–Naproxen Combination for 12-Hour Pain Relief Pharmacy Times